Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balances at Dec. 31, 2019 $ 33,150,000 $ 1,000 $ 150,280,000 $ 26,000 $ (117,157,000)
Balance (in shares) at Dec. 31, 2019   551,000      
Common stock issued (in shares)   5,000      
Stock-based compensation 1,047,000   1,047,000    
Other comprehensive loss (22,000)     (22,000)  
Net loss (7,701,000)       (7,701,000)
Balances at Mar. 31, 2020 26,474,000 $ 1,000 151,327,000 $ 4,000 (124,858,000)
Balance (in shares) at Mar. 31, 2020   556,000      
Balances at Dec. 31, 2020 21,147,000 $ 7,000 174,342,000   (153,202,000)
Balance (in shares) at Dec. 31, 2020   3,189,000      
Common stock issued, net 65,000   65,000    
Common stock issued (in shares)   35      
Stock-based compensation 1,169,000 $ 35,000 1,169,000    
Net loss (7,236,000)       (7,236,000)
Balances at Mar. 31, 2021 $ 15,145,000 $ 7,000 $ 175,576,000   $ (160,438,000)
Balance (in shares) at Mar. 31, 2021   3,259,000